From October 1, 2021 to December 31, 2021, the company has repurchased 4,748,693 shares, representing 0.32% for CNY 97.94 million. With this, the company has completed the repurchase of 7,790,608 shares, representing 0.52% for CNY 149.99 million under the buyback announced on August 6, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.28 CNY | +0.64% | -1.48% | +17.79% |
13/05 | Huahai Pharmaceutical's Unit Gets Nod to Register Atomoxetine Hydrochloride Oral Solution | MT |
02/05 | Huahai Pharmaceutical's Q1 Profit Jumps 57%, Income Up 21% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.79% | 346.94Cr | |
+39.82% | 73TCr | |
+31.34% | 59TCr | |
-7.31% | 35TCr | |
+14.23% | 32TCr | |
+0.86% | 27TCr | |
+13.47% | 24TCr | |
-6.63% | 20TCr | |
+7.49% | 20TCr | |
+4.51% | 16TCr |
- Stock Market
- Equities
- 600521 Stock
- News Zhejiang Huahai Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 6, 2021.